(3,5-Difluorophenyl)glyoxylic acid → 3-[N'-(3,5-Difluorophenyl-alpha-oxoacetyl)-L-alaninyl]amino-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepin-2-one
反応式
[F:1][C:2]1[CH:3]=[C:4]([C:9](=[O:13])[C:10]([OH:12])=O)[CH:5]=[C:6]([F:8])[CH:7]=1.[NH2:14][C@H:15]([C:17]([NH:19][CH:20]1[N:26]=[C:25]([C:27]2[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=2)[C:24]2[CH:33]=[CH:34][CH:35]=[CH:36][C:23]=2[N:22]([CH3:37])[C:21]1=[O:38])=[O:18])[CH3:16]>>[F:8][C:6]1[CH:5]=[C:4]([C:9](=[O:13])[C:10]([NH:14][C@H:15]([C:17]([NH:19][CH:20]2[N:26]=[C:25]([C:27]3[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=3)[C:24]3[CH:33]=[CH:34][CH:35]=[CH:36][C:23]=3[N:22]([CH3:37])[C:21]2=[O:38])=[O:18])[CH3:16])=[O:12])[CH:3]=[C:2]([F:1])[CH:7]=1参加物
3
実験手順
Following General Procedure D above using 3,5-difluoro-α-oxoacetic acid (Example O) and 3-(L-alaninyl)amino-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepin-2-one (Example 8-B), the title compound was prepared as a solid (mp.=128-129° C.). The product was purified by LC 2000 chromatography, eluting with hexanes/ethyl acetate (30:70).
後処理
- customThe product was purified by LC 2000 chromatography
- washeluting with hexanes/ethyl acetate (30:70)
出典と根拠
- ORDレコード
- ord-8dde0f94dd8848b09e1bb98c57310246
- 出典データセット
- uspto-grants-2003_10
- 特許番号
- US06632811B2
反応ノート
読み込み中…